About HLL Biotech Limited
Data last updated:
HLL Biotech Limited is a private limited union government company based in Thiruvananthapuram, Kerala, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 March 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U24290KL2012GOI030732. Its GSTIN is 33AACCH8828A1ZW (Tamil Nadu). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹285 Cr and a paid-up capital of ₹27.49 Cr. It is led by directors including Amitabh Soni and Vijay Nehra.
Its last annual general meeting (AGM) was held on 11 December 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thiruvananthapuram, Kerala.
As per the financials filed for FY 2024, the company reported a revenue of ₹17.08 Cr, a decline of 68% compared to the previous year. For the same year it recorded a net loss of ₹16.23 Cr (net margin -95%) and EBITDA of -₹74.07 Lakh (EBITDA margin -4.3%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 110% over five years.
The company has about 99 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: HLL Biotech. As per MCA filings, the company has open charges of ₹409 Cr and satisfied charges of ₹50 Cr on record. Court records list 42 cases involving the company, including 15 filed by the company and 27 filed against it; 3 cases are pending. The company has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 funding round), with disclosed funding of ₹96.88 Cr; the latest was in March 2021. Its 3 peer companies in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Vamsi Pharma Private Limited with revenue of ₹17.11 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hllbiotech.com.
Company details
Contact details
HLL Biotech Limited's registered office is in Thiruvananthapuram, Kerala. Its website is hllbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressKumari Geetha S Neena Mg Geena Jayaprakash (Joint Owners), Aswathi Neens Ward No.42 Door No. 3133, Thiruvananthapuram, Kerala, India – 695012
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
To see the full contact details of HLL Biotech Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
HLL Biotech operates one associated brand: HLL Biotech. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A CDMO focused on manufacturing vaccines for healthcare partners. | hllbiotech.com |
Financials of HLL Biotech Limited
FY 2024 filings availableHLL Biotech Limited reported revenue of ₹17.08 Cr (down 68% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 68% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 110%. EBITDA fell 102% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹74.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹16.23 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -4.3% | ||||
| Net Profit Margin | -95% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of HLL Biotech Limited, buy the company report.
Board of directors of HLL Biotech Limited
HLL Biotech has 3 current directors and 39 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vijay Nehra Also directs: HLL Lifecare Limited, HLL Medipark Limited | Nominee Director | 01 Oct 2025 | 1 Years 0 Months | Current |
| Amitabh Soni | Director | 25 Apr 2025 | 1 Years 5 Months | Current |
| Hoveyda Abbas Also directs: Goa Antibiotics and Pharmaceuticals Limited, HLL Lifecare Limited, HLL Infra Tech Services Limited and 1 more | Nominee Director | 25 Jun 2025 | 1 Years 3 Months | Current |
Peer comparison
HLL Biotech Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vamsi Pharma Private Limited | ₹17.11 Cr (FY 2025) | 16.0% | Hyderabad, Telangana, India | |||
| HLL Biotech Limitedthis company | ₹17.08 Cr (FY 2024) | -₹16.23 Cr | -95% | -68.0% | 99 | Thiruvananthapuram, Kerala, India |
| JMM Formulation Private Limited | ₹17.04 Cr (FY 2025) | 30.0% | Kala Amb, Himachal Pradesh, India | |||
| Anchor Pharma Private Limited | ₹17.02 Cr (FY 2025) | 11.0% | Daman, Daman and Diu, India |
To see the full peer comparison of HLL Biotech Limited, buy the company report.
Auditor
HLL Biotech Limited is audited by Sanjiv Shah & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Sanjiv Shah & Associates | FY 2023 | 003572S |
Shareholding
The shareholding of HLL Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of HLL Biotech Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2017 | 100113057 | Sbicap Trustee Company Limited | ₹309 Cr | Open | |
| 30 May 2016 | 100033461 | State Bank of Travancore | ₹100 Cr | Open | |
| 29 Jun 2016 | 100099523 | Hdfc Bank Limited | ₹50 Cr | Satisfied |
To see the full charge records of HLL Biotech Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
HLL Biotech Limited has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 funding round), with disclosed funding of ₹96.88 Cr; the latest was in March 2021.
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: President of India Seller: HLL Lifecare Limited |
| May 2015 | Funding round | ₹96.88 Cr | Investors: HLL Lifecare Limited |
| Nov 2012 | Acquisition | ₹178 Cr | Buyer: HLL Lifecare Limited |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
HLL Biotech Limited has 42 court cases on record: 15 filed by HLL Biotech, 27 filed against it. 3 cases are pending and 39 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 29 | 16 | 1 |
| District courts | 9 | 7 | 2 |
| NCLT | 2 | 2 | 0 |
| NCLAT | 2 | 2 | 0 |
Cases on record (5 of 42)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chengalpattu, Tamil Nadu | Court case (COS) | Filed against the company by Metec Design and Construction Engineers India Pvt Ltd., | Pending |
| High Court, TAMIL NADU | Interim or miscellaneous application | Filed against the company by M/S.Shapoorji Pallonji and Company Private Ltd. | Pending |
| District court, Kancheepuram, Tamil Nadu | Execution petition | Filed against the company by M/S Metec Design and Constrn., Engineers India Pvt., Ltd., | Pending |
| NCLAT, NCLAT Chennai | Court case (Restoration App) | Filed against the company by Avant Garde Cleanroom & Engg. Solutions Private Limited | Disposed |
| High Court | Appeal | Filed against the company by Eta Engineering Pvt Ltd Rep by Its Authorised Signatory, M/S.Rajesh S S, 9444018421,M.Praveen ,P.K.Deepa Divyavarthini,R.Nandhini-Ms/3379/2016 | Disposed |
To see the full case history of HLL Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
HLL Biotech Limited was last rated by Icra on 18 Mar 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 18 Mar 2022 |
To see the full credit ratings and regulatory alerts of HLL Biotech Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for HLL Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
HLL Biotech Limited has a workforce of 99 employees on its EPFO records as of Oct 22, 2024, across 1 active EPFO establishment.
GST
HLL Biotech has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AACCH8828A1ZW | Tamil Nadu | Active | 01 Jul 2017 |
| 36AACCH8828A1ZQ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of HLL Biotech Limited, buy the company report.
Recent activity
HLL Biotech Limited has 38 board changes on record since 2013: 6 appointments and 32 cessations. The latest: Roli Singh ceased to be Nominee Director on 01 Oct 2025.
34 earlier events are in the company report.
Frequently asked questions
HLL Biotech is an active private limited union government company based in Thiruvananthapuram, Kerala, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 March 2012 (14+ years old) and is registered under CIN U24290KL2012GOI030732.
HLL Biotech has 3 current directors:
- Vijay Nehra - Nominee Director
- Amitabh Soni - Director
- Hoveyda Abbas - Nominee Director
The latest financial statements of HLL Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 11 December 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of HLL Biotech is 33AACCH8828A1ZW, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AACCH8828A1ZQ (Telangana).
The CIN (Corporate Identification Number) of HLL Biotech is U24290KL2012GOI030732. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
HLL Biotech has 42 court cases on record: 15 filed by the company and 27 filed against it. 3 are pending. Most are in the high courts.
HLL Biotech was incorporated on 12 March 2012, making it 14+ years old. It is registered with the Registrar of Companies, Ernakulam.
HLL Biotech has 3 deals on record (1 secondary share transfer, 1 acquisition, 1 funding round), with disclosed funding of ₹96.88 Cr; the latest was in March 2021.
The peers of HLL Biotech by revenue are Vamsi Pharma Private Limited, JMM Formulation Private Limited, Anchor Pharma Private Limited, all in the Pharma industry (Contract Research, Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Roli Singh ceased to be Nominee Director on 01 Oct 2025. Vijay Nehra was appointed as Nominee Director on 01 Oct 2025. Hoveyda Abbas was appointed as Nominee Director on 25 Jun 2025. HLL Biotech has 38 board changes on record in total.
HLL Biotech can be reached through the website hllbiotech.com. Its registered office is in Thiruvananthapuram, Kerala, India.